Piper Sandler analyst Arvind Ramnani upgraded Clearwater Analytics to Overweight, increasing the price target to $36 from $28 ...

We recently published a list of 10 Small–Cap Stocks Insiders Are Selling Recently. In this article, we are going to take a ...

Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Enfusion, Inc. ('Enfusion') (NYSE:ENFN) and Clearwater ...

Investing.com -- Morgan Stanley downgraded Enfusion Inc (NYSE:ENFN) stock to "Equal-weight" from "Overweight" following Clearwater Analytics' proposed $1.5 billion acquisition at $11.25 per share ...

Q4 2024 Management View CEO Sandeep Sahai highlighted the company's strong Q4 performance with $126.5 million in revenue, marking 28% year-on-year growth. He emphasized the achievement of a 116% net ...

Clearwater Analytics' $1.5 billion acquisition of Enfusion is a strategic move to expand its portfolio management offerings and enhance its SaaS revenue growth. Enfusion's strong business model ...

MILWAUKEE--(BUSINESS WIRE)--Ademi LLP is investigating Enfusion (NYSE: ENFN) for possible breaches of fiduciary duty and other violations of law in its transaction with Clearwater. Click here to ...

(RTTNews) - Clearwater Analytics (CWAN) and Enfusion (ENFN) announced a definitive merger agreement for Clearwater to acquire Enfusion. Enfusion shareholders will receive consideration equal to $ ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

BOISE, Idaho & CHICAGO, January 13, 2025--Clearwater Analytics (NYSE: CWAN) ("Clearwater") and Enfusion, Inc. (NYSE: ENFN) ("Enfusion") today announced their entry ...